PhRMA Executive VP: ‘The 340B drug discount program is being exploited for profit by powerful interests’
Scott LaGanga, Executive Vice President of Public Affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA), said that the 340B program is being misused by influential entities, which negatively impacts access to affordable…









